Issued 2026-09-16 at $1.44 · now $1.44 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, MBOT has typically landed between $1.01 and $2.17 — a range of −29.6% to +50.6% from the issuance price $1.44.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,993 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($1.44) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where MBOT has typically landed a month from the 2026-09-16 close of $1.44 — the range is history, not a prediction.
- now $1.44 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.38 (-4.3%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $1.23–$1.53
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $1.01–$2.17
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2016-05-11 | −88.4% | −88.4% | +0.0% |
| 2016-05-12 | −87.6% | −87.6% | +0.0% |
| 2016-05-25 | −87.6% | −87.8% | +1.7% |
| 3 best | |||
| 2018-12-20 | +551.7% | +0.0% | +582.1% |
| 2019-01-04 | +483.5% | +0.0% | +483.5% |
| 2018-12-19 | +473.7% | −4.6% | +550.7% |
4,993 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
24 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-04-01 | Laxminarain Prattipati | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2026-04-01 | Burell Scott R | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2026-04-01 | Wenderow Tal Baruch | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2026-04-01 | Madden Martin J. | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2026-04-01 | Wilson David James | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2026-04-01 | Stockburger Aileen Ptucha | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2026-02-18 | Diaz-Cartelle Juan | officer | Award / grant | 105,000 | 105,000 | Form 4 |
| 2026-02-18 | Vaknin Rachel | officer | Award / grant | 105,000 | 105,000 | Form 4 |
| 2026-02-18 | Sharon Simon | officer | Award / grant | 105,000 | 105,000 | Form 4 |
| 2026-02-18 | Gadot Harel | director | Award / grant | 480,000 | 480,000 | Form 4 |
| 2025-02-05 | Diaz-Cartelle Juan | officer | Award / grant | 42,000 | 42,000 | Form 4 |
| 2025-02-05 | Vaknin Rachel | officer | Award / grant | 48,125 | 48,125 | Form 4 |
| 2025-02-05 | Gadot Harel | director | Award / grant | 228,000 | 228,000 | Form 4 |
| 2025-02-05 | Sharon Simon | officer | Award / grant | 43,750 | 43,750 | Form 4 |
| 2025-01-28 | Madden Martin J. | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2025-01-28 | Wenderow Tal Baruch | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2025-01-28 | Wilson David James | director | Award / grant | 20,000 | 20,000 | Form 4 |
| 2025-01-28 | Burell Scott R | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2025-01-28 | Stockburger Aileen Ptucha | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2025-01-28 | Laxminarain Prattipati | director | Award / grant | 10,000 | 10,000 | Form 4 |
| 2024-02-26 | Gadot Harel | director | Award / grant | 12,000 | 12,000 | Form 4 |
| 2024-02-26 | Sharon Simon | officer | Award / grant | 8,750 | 8,750 | Form 4 |
| 2024-02-26 | Diaz-Cartelle Juan | officer | Award / grant | 10,500 | 10,500 | Form 4 |
| 2024-02-26 | Vaknin Rachel | officer | Award / grant | 4,375 | 4,375 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.